Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease - Université de Lorraine Access content directly
Journal Articles Alimentary Pharmacology & Therapeutics (Suppl) Year : 2015

Dates and versions

hal-01681028 , version 1 (11-01-2018)

Identifiers

Cite

S. Paul, X. Roblin, L. Peyrin-Biroulet. Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics (Suppl), 2015, 42 (7), pp.939 - 940. ⟨10.1111/apt.13335⟩. ⟨hal-01681028⟩
19 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More